Amiodarone is a potent and widely used antiarrhythmic drug that bears
a structural resemblance to thyroid hormones. The high iodine content
of the drug determines that amiodarone induces changes in circulating
concentrations of thyroid hormones, largely through inhibition of conv
ersion of thyroxine (T4) to tri-iodothyronine (T3). Amiodarone treatme
nt typically results in a rise in serum T4, often to above the normal
range, associated with a fall in circulating T3. These biochemical cha
nges are found in subjects who remain clinically euthyroid. In additio
n to changes in circulating thyroid hormones found in euthyroid subjec
ts, overt thyrotoxicosis and hypothyroidism may complicate amiodarone
treatment. Amiodarone-induced thyrotoxicosis is more common in areas o
f iodine deficiency, whereas hypothyroidism is more common in iodine-r
ich parts of the world.